{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Integrated Proteins Ltd
Is Integ. Proteins overvalued or undervalued?
As of November 27, 2025, Integ. Proteins is considered undervalued with an attractive investment appeal, reflected in its favorable PE ratio of 42.60 and EV to EBITDA of 14.06, despite a year-to-date return of -49.13%, while showing a strong three-year return of 97.78%.
Integrated Proteins Faces Intense Selling Pressure Amidst Prolonged Downtrend
Integrated Proteins Ltd is currently experiencing extreme selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling signals a challenging phase for the edible oil company as it continues to face consecutive losses and a significant downtrend over the past year.
Is Integ. Proteins overvalued or undervalued?
As of November 10, 2025, Integ. Proteins is considered undervalued with an attractive valuation grade, a PE ratio of 42.60, and strong recent performance, significantly outperforming peers like Manorama Industries and CIAN Agro.
How has been the historical performance of Integ. Proteins?
Integ. Proteins has shown significant growth, with net sales reaching 21.50 Cr in March 2025, up from 0.24 Cr in March 2024. The company also reported increased operating profit, profit before tax, and profit after tax, alongside a rise in earnings per share to 0.71.
Are Integ. Proteins latest results good or bad?
Integrated Proteins' latest Q2 FY26 results show a recovery with net sales of ₹4.20 crores and a small profit of ₹0.05 crores, but significant challenges remain due to erratic revenue patterns and thin profitability, raising concerns about long-term viability.
Integrated Proteins Q2 FY26: Micro-Cap Edible Oil Processor Shows Signs of Life After Years of Dormancy
Integrated Proteins Limited, a Jamnagar-based edible oil processor, reported a net profit of ₹0.05 crores for Q2 FY26, marking a tentative return to operational activity after years of minimal business. The micro-cap company, with a market capitalisation of just ₹13.00 crores, recorded net sales of ₹4.20 crores during the quarter—a dramatic contrast to the near-zero revenues witnessed in preceding quarters. Despite this operational revival, the stock remains deeply troubled, down 21.92% over the past year and trading at ₹38.25 as of November 7, 2025, following a 5.00% single-day gain.
Integrated Proteins Ltd Faces Significant Selling Pressure with 25.64% Yearly Loss and 51.55% Decline YTD
Integrated Proteins Ltd is experiencing notable selling pressure, continuing a trend of losses. Despite a recent monthly increase, the stock has faced significant declines over three months and year-to-date. The erratic trading pattern and broader sector decline are contributing to negative market sentiment surrounding the company.
Why is Integ. Proteins falling/rising?
As of 31-Oct, Integrated Proteins Ltd's stock price has risen to Rs 36.43, marking a 4.99% increase and a 21.43% gain over the past week, despite a significant year-to-date decline of 51.55%. The stock has shown erratic trading patterns and decreased investor participation, contrasting with a slight decline in the benchmark Sensex.
Integrated Proteins Ltd Faces Selling Pressure with 51.55% Year-to-Date Loss Amid Volatility
Integrated Proteins Ltd is experiencing notable selling pressure, marked by a series of losses over the past three months and a significant year-to-date decline. Despite a recent uptick in performance, the stock's overall trend remains concerning, with erratic trading patterns and challenges within the broader sector.
Is Integ. Proteins overvalued or undervalued?
As of October 29, 2025, Integ. Proteins is fairly valued with a PE ratio of 48.59, higher than some peers, and while it has outperformed the Sensex recently, it has underperformed year-to-date.
Integrated Proteins Ltd Faces Significant Selling Pressure with 56.04% Year-to-Date Loss
Integrated Proteins Ltd is experiencing notable selling pressure, marked by a significant decline over the past year and three months. Despite a brief intraday gain, the stock's year-to-date performance remains poor, influenced by erratic trading patterns and a downturn in the solvent extraction sector.
Why is Integ. Proteins falling/rising?
As of 28-Oct, Integrated Proteins Ltd is currently priced at Rs 31.50, reflecting a 5.0% increase today and a 12.02% rise over the past month. However, the stock has faced low liquidity and significant year-to-date declines, down 58.11%, contrasting with the broader market's performance.
Integrated Proteins Ltd Faces Significant Selling Pressure with Year-to-Date Loss of 58.11%
Integrated Proteins Ltd is experiencing notable selling pressure, with a year-to-date decline of 58.11%. Despite recent short-term gains, the stock has faced significant losses over three months and the past year. Today's trading showed limited movement, reflecting broader challenges within the Solvent Extraction sector.
Integrated Proteins Ltd Surges 5% Today, Outperforming Sensex Amidst Market Decline
Integrated Proteins Ltd, a microcap in the edible oil sector, is experiencing notable buying activity, with a 5.00% increase today, contrasting with a slight decline in the Sensex. Despite recent gains, the stock has faced significant year-to-date challenges and volatility, reflecting mixed performance trends over various timeframes.
Integrated Proteins Ltd Gains 7.41% This Week Despite Year-to-Date Decline of 60.10%
Integrated Proteins Ltd is experiencing notable buying activity amid mixed trading performance. While the stock has recently outperformed the Sensex, it faces longer-term challenges with significant declines year-to-date. The broader solvent extraction sector is also under pressure, influencing investor sentiment and trading dynamics.
Why is Integ. Proteins falling/rising?
As of 17-Oct, Integrated Proteins Ltd is currently priced at Rs 29.32, reflecting a recent upward trend with a total return of 41.57% over the last eight days. However, it has a significant year-to-date decline of 61.01% and mixed technical signals, indicating potential caution among investors despite short-term outperformance against the Sensex.
Integrated Proteins Ltd Faces Significant Selling Pressure with 61.01% Year-to-Date Loss
Integrated Proteins Ltd is experiencing significant selling pressure, marked by consecutive losses and a sharp decline of 26.93% over the past week. The stock has a year-to-date loss of 61.01% and remains below key moving averages, reflecting a bearish trend amid broader sector challenges.
Integrated Proteins Ltd Surges 4.89% Today, Cumulative Weekly Gains Reach 26.82%
Integrated Proteins Ltd, a microcap in the edible oil sector, is experiencing heightened buying activity, significantly outperforming the broader market. The stock has gained 26.82% over the past week, despite a challenging year-to-date performance. Recent momentum suggests a shift in market sentiment, with strong buyer interest noted.
Why is Integ. Proteins falling/rising?
As of 15-Oct, Integrated Proteins Ltd's stock price is Rs 26.70, up 4.87%, with a recent six-day gain of 28.92%. Despite this short-term recovery, the stock's year-to-date performance is down 64.49%, and investor participation has decreased significantly.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
